发明名称 Preparation and use of crystalline beta-D-nicotinamide riboside
摘要 Provided herein are crystalline beta-D-nicotinamide riboside chloride compositions and methods of preparation and use thereof. Also provided are related pharmaceutical compositions and methods of use thereof. The crystalline beta-D-nicotinamide riboside chloride compositions may be used to treat a disease or disorder that would benefit from increased NAD levels including a mitochondrial disease or disorder, insulin resistance, a metabolic syndrome, diabetes, obesity, or for increasing insulin sensitivity in a subject.
申请公布号 AU2015270130(A1) 申请公布日期 2016.12.15
申请号 AU20150270130 申请日期 2015.06.02
申请人 GlaxoSmithKline Intellectual Property (No.2) Limited 发明人 Szczepankiewicz, Bruce;Koppetsch, Karsten;Perni, Robert B.
分类号 C07H19/048;A61K31/706;A61P3/00;A61P21/00;A61P31/10;A61P43/00;C07H1/00 主分类号 C07H19/048
代理机构 代理人
主权项
地址